GHRL and pancreatic insulinoma: To investigate the reason that might reduce the plasma levels of acylated ghrelin in patients with insulinoma, we compared the plasma levels of acylated ghrelin in obese patients with those in obese volunteer controls, and the levels of acylated ghrelin in nonobese patients (BMI < 29) with that in nonobese controls.